Terms: = Cervical cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Prognosis
12 results:
1. Factors affecting cervical cancer screening among Yemeni immigrant women in Klang Valley, Malaysia: A cross sectional study.
Al-Oseely S; Abdul Manaf R; Ismail S
PLoS One; 2023; 18(12):e0290152. PubMed ID: 38100481
[TBL] [Abstract] [Full Text] [Related]
2. Conization before radical hysterectomy in patients with early-stage cervical cancer: A Korean multicenter study (COBRA-R).
Kim SI; Nam SH; Hwangbo S; Kim Y; Cho HW; Suh DH; Song JY; Kim JW; Choi CH; Kim DY; Lee M
Gynecol Oncol; 2023 Jun; 173():88-97. PubMed ID: 37105062
[TBL] [Abstract] [Full Text] [Related]
3. [Relationship between serum folate and CIN1 prognosis and its interaction with HR-HPV infection].
Qi Z; Ding L; Meng D; Liu H; Wang J; Song L; Lyu YJ; Jia HX; Hao M; Tian ZQ; Wang JT
Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):866-871. PubMed ID: 34407593
[No Abstract] [Full Text] [Related]
4. FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism.
Zhang C; Liao Y; Liu P; Du Q; Liang Y; Ooi S; Qin S; He S; Yao S; Wang W
Theranostics; 2020; 10(15):6561-6580. PubMed ID: 32550890
[TBL] [Abstract] [Full Text] [Related]
5. Survival and recurrence in stage II endometrial cancers in relation to uterine risk stratification after introduction of lymph node resection and omission of postoperative radiotherapy: a Danish Gynecological cancer Group Study.
Ørtoft G; Høgdall C; Hansen ES; Dueholm M
J Gynecol Oncol; 2020 Mar; 31(2):e22. PubMed ID: 31912677
[TBL] [Abstract] [Full Text] [Related]
6. Association of iRhom1 and iRhom2 expression with prognosis in patients with cervical cancer and possible signaling pathways.
Xu Q; Chen C; Liu B; Lin Y; Zheng P; Zhou D; Xie Y; Lin Y; Guo C; Liu J; Li L
Oncol Rep; 2020 Jan; 43(1):41-54. PubMed ID: 31661139
[TBL] [Abstract] [Full Text] [Related]
7. Overexpression of ezrin and galectin-3 as predictors of poor prognosis of cervical cancer.
Li M; Feng YM; Fang SQ
Braz J Med Biol Res; 2017 Mar; 50(4):e5356. PubMed ID: 28355349
[TBL] [Abstract] [Full Text] [Related]
8. Altered expression of survivin, fas and fasL contributed to cervical cancer development and metastasis.
Wu SF; Zhang JW; Qian WY; Yang YB; Liu Y; Dong Y; Zhang ZB; Zhu YP; Feng YJ
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(15):2044-50. PubMed ID: 23280017
[TBL] [Abstract] [Full Text] [Related]
9. Apoptosis induction in Jurkat cells and scd95 levels in women's sera are related with the risk of developing cervical cancer.
Aguilar-Lemarroy A; Romero-Ramos JE; Olimon-Andalon V; Hernandez-Flores G; Lerma-Diaz JM; Ortiz-Lazareno PC; Morgan-Villela G; Del Toro-Arreola S; Bravo-Cuellar A; Jave-Suarez LF
BMC Cancer; 2008 Apr; 8():99. PubMed ID: 18405371
[TBL] [Abstract] [Full Text] [Related]
10. Expression of fas ligand and bcl-2 in cervical carcinoma and their prognostic significance.
Munakata S; Watanabe O; Ohashi K; Morino H
Am J Clin Pathol; 2005 Jun; 123(6):879-85. PubMed ID: 15899779
[TBL] [Abstract] [Full Text] [Related]
11. fas ligand expression in cervical adenocarcinoma: relevance to lymph node metastasis and tumor progression.
Kase H; Aoki Y; Tanaka K
Gynecol Oncol; 2003 Jul; 90(1):70-4. PubMed ID: 12821344
[TBL] [Abstract] [Full Text] [Related]
12. Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients.
Zuna RE; Behrens A
J Natl Cancer Inst; 1996 Jul; 88(14):980-7. PubMed ID: 8667429
[TBL] [Abstract] [Full Text] [Related]
